1037 related articles for article (PubMed ID: 12679445)
1. Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers.
Horwitz MJ; Tedesco MB; Sereika SM; Hollis BW; Garcia-Ocaña A; Stewart AF
J Clin Endocrinol Metab; 2003 Apr; 88(4):1603-9. PubMed ID: 12679445
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid hormone (PTH)-related protein(1-36) is equipotent to PTH(1-34) in humans.
Everhart-Caye M; Inzucchi SE; Guinness-Henry J; Mitnick MA; Stewart AF
J Clin Endocrinol Metab; 1996 Jan; 81(1):199-208. PubMed ID: 8550752
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid hormone-related protein-(1--36) stimulates renal tubular calcium reabsorption in normal human volunteers: implications for the pathogenesis of humoral hypercalcemia of malignancy.
Syed MA; Horwitz MJ; Tedesco MB; Garcia-Ocaña A; Wisniewski SR; Stewart AF
J Clin Endocrinol Metab; 2001 Apr; 86(4):1525-31. PubMed ID: 11297578
[TBL] [Abstract][Full Text] [Related]
4. Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D.
Horwitz MJ; Tedesco MB; Sereika SM; Syed MA; Garcia-Ocaña A; Bisello A; Hollis BW; Rosen CJ; Wysolmerski JJ; Dann P; Gundberg C; Stewart AF
J Bone Miner Res; 2005 Oct; 20(10):1792-803. PubMed ID: 16160737
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the in vivo biochemical responses to exogenous parathyroid hormone-(1-34) [PTH-(1-34)] and PTH-related peptide-(1-34) in man.
Fraher LJ; Hodsman AB; Jonas K; Saunders D; Rose CI; Henderson JE; Hendy GN; Goltzman D
J Clin Endocrinol Metab; 1992 Aug; 75(2):417-23. PubMed ID: 1322424
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone-related protein-(1-36) is biologically active when administered subcutaneously to humans.
Henry JG; Mitnick M; Dann PR; Stewart AF
J Clin Endocrinol Metab; 1997 Mar; 82(3):900-6. PubMed ID: 9062504
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the pharmacokinetics of parenteral parathyroid hormone-(1-34) [PTH-(1-34)] and PTH-related peptide-(1-34) in healthy young humans.
Fraher LJ; Klein K; Marier R; Freeman D; Hendy GN; Goltzman D; Hodsman AB
J Clin Endocrinol Metab; 1995 Jan; 80(1):60-4. PubMed ID: 7829640
[TBL] [Abstract][Full Text] [Related]
8. Dissociation of bone formation from resorption during 2-week treatment with human parathyroid hormone-related peptide-(1-36) in humans: potential as an anabolic therapy for osteoporosis.
Plotkin H; Gundberg C; Mitnick M; Stewart AF
J Clin Endocrinol Metab; 1998 Aug; 83(8):2786-91. PubMed ID: 9709948
[TBL] [Abstract][Full Text] [Related]
9. A 7-day continuous infusion of PTH or PTHrP suppresses bone formation and uncouples bone turnover.
Horwitz MJ; Tedesco MB; Sereika SM; Prebehala L; Gundberg CM; Hollis BW; Bisello A; Garcia-Ocaña A; Carneiro RM; Stewart AF
J Bone Miner Res; 2011 Sep; 26(9):2287-97. PubMed ID: 21544866
[TBL] [Abstract][Full Text] [Related]
10. Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties: a comparison of human parathyroid hormone 1-34, parathyroid hormone-related protein 1-36, and SDZ-parathyroid hormone 893.
Stewart AF; Cain RL; Burr DB; Jacob D; Turner CH; Hock JM
J Bone Miner Res; 2000 Aug; 15(8):1517-25. PubMed ID: 10934650
[TBL] [Abstract][Full Text] [Related]
11. Inhibition by human interleukin-1 alpha of parathyroid hormone-related peptide effects on renal calcium and phosphorus metabolism in the rat.
Tørring O; Turner RT; Carter WB; Firek AF; Jacobs CA; Heath H
Endocrinology; 1992 Jul; 131(1):5-13. PubMed ID: 1319327
[TBL] [Abstract][Full Text] [Related]
12. Resistance to the phosphaturic and calcemic actions of parathyroid hormone during phosphate depletion. Prevention by 1,25-dihydroxyvitamin D3.
Gloor HJ; Bonjour JP; Caverzasio J; Fleisch H
J Clin Invest; 1979 Mar; 63(3):371-7. PubMed ID: 34630
[TBL] [Abstract][Full Text] [Related]
13. Aging and renal responsiveness to parathyroid hormone in healthy men.
Halloran BP; Lonergan ET; Portale AA
J Clin Endocrinol Metab; 1996 Jun; 81(6):2192-7. PubMed ID: 8964850
[TBL] [Abstract][Full Text] [Related]
14. Synthetic human parathyroid hormone-related protein and rat renal electrolyte transport.
Carney SL; Ray C; Ebeling PR; Martin TJ; Gillies AH
Miner Electrolyte Metab; 1991; 17(1):41-5. PubMed ID: 1663207
[TBL] [Abstract][Full Text] [Related]
15. Renal 1,25-dihydroxyvitamin D, phosphaturic, and cyclic-AMP responses to intravenous synthetic human parathyroid hormone-(1-34) administration in normal subjects.
Slovik DM; Daly MA; Potts JT; Neer RM
Clin Endocrinol (Oxf); 1984 Apr; 20(4):369-75. PubMed ID: 6325049
[TBL] [Abstract][Full Text] [Related]
16. Plasma intact parathyroid hormone (PTH) and PTH-related peptide in familial benign hypercalcemia: greater responsiveness to endogenous PTH than in primary hyperparathyroidism.
Firek AF; Kao PC; Heath H
J Clin Endocrinol Metab; 1991 Mar; 72(3):541-6. PubMed ID: 1997510
[TBL] [Abstract][Full Text] [Related]
17. Effects of treatment of malignancy-associated hypercalcemia on serum parathyroid hormone-related protein.
Budayr AA; Zysset E; Jenzer A; Thiébaud D; Ammann P; Rizzoli R; Jaquet-Müller F; Bonjour JP; Gertz B; Burckhardt P
J Bone Miner Res; 1994 Apr; 9(4):521-6. PubMed ID: 8030440
[TBL] [Abstract][Full Text] [Related]
18. Rapid development of renal resistance to low doses of synthetic bovine parathyroid hormone fragment 1-34. Dissociation of urinary cyclic adenosine monophosphate, phosphaturic, and calciuric responses.
Law WM; Heath H
J Clin Invest; 1983 Sep; 72(3):1106-13. PubMed ID: 6309905
[TBL] [Abstract][Full Text] [Related]
19. [Effect of parathyroid hormone-related protein on Na(+)-dependent phosphate transport in renal brush border membrane vesicles in rats].
Saito K; Hirano K; Kubota M; Tomino Y; Koide H
Nihon Jinzo Gakkai Shi; 1991 Mar; 33(3):267-73. PubMed ID: 2062012
[TBL] [Abstract][Full Text] [Related]
20. 1,25-dihydroxyvitamin D3 as well as its analogue OCT lower blood calcium through inhibition of bone resorption in hypercalcemic rats with continuous parathyroid hormone-related peptide infusion.
Endo K; Katsumata K; Hirata M; Masaki T; Kubodera N; Nakamura T; Ikeda K; Ogata E
J Bone Miner Res; 2000 Jan; 15(1):175-81. PubMed ID: 10646127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
